Speciality: Oncology
Description:
Dr. Srinivas K G presents a compelling retrospective analysis titled "ESMO Breast Cancer 2022: P REALITY X" in this insightful video. The discussion delves into the real-world efficacy and clinical outcomes of a specific breast cancer treatment regimen, as examined during the ESMO Breast Cancer 2022 conference. Dr. Srinivas meticulously reviews the data, highlighting key findings, patient responses, and the implications for future therapeutic strategies. His expertise provides valuable perspectives for oncologists and researchers seeking to optimize breast cancer management.
The video explores the retrospective study design, patient demographics, and survival outcomes analyzed in the P REALITY X trial. Dr. Srinivas emphasizes the importance of real-world evidence in complementing randomized clinical trials, offering a more comprehensive understanding of treatment effectiveness in diverse populations. He also addresses potential limitations and biases inherent in retrospective analyses, ensuring a balanced interpretation of the results. This session is a must-watch for medical professionals aiming to stay updated on the latest advancements in breast cancer research.
Dr. Srinivas K G’s detailed breakdown of the P REALITY X study serves as an invaluable resource for the oncology community. By bridging the gap between clinical trials and real-world practice, his analysis fosters a deeper appreciation for evidence-based decision-making. Stay tuned for more expert discussions and cutting-edge insights in upcoming videos. Your journey towards mastering breast cancer therapeutics continues here!
See More Webinars @ Hidoc Webinars
1.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
2.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
3.
Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer
4.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
5.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
1.
Therapeutic Advances in RNA-Based Hematologic Therapies
2.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
3.
Developmental Changes in Pediatric Coagulation Networks
4.
Clinical Guidelines for Tumor Evolution Tracking Using Dynamic Molecular Profiling
5.
Seeing the Unseen: Examining Chancroid Through Images
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Understanding the Importance of Early Cancer Detection
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation